Modelling A.I. in Economics

Exclusive to premium members (Forecast)

Outlook: OGI Organigram Holdings Inc. is assigned short-term B3 & long-term B3 estimated rating.
AUC Score : What is AUC Score?
Short-Term Revised1 :
Dominant Strategy : Hold
Time series to forecast n: for Weeks2
ML Model Testing : Modular Neural Network (Market Direction Analysis)
Hypothesis Testing : Lasso Regression
Surveillance : Major exchange and OTC

1The accuracy of the model is being monitored on a regular basis.(15-minute period)

2Time series is updated based on short-term trends.

Key Points

- Increased market share through strategic acquisitions and partnerships, driving revenue growth. - Expansion into new markets, particularly international markets, leading to increased sales and brand recognition. - Continued investment in research and development, resulting in innovative new products and improved production efficiency.


Organigram Holdings Inc., also known as Organigram, is a Canadian licensed producer of cannabis and cannabis-derived products. The company was founded in 2013 and is headquartered in Moncton, New Brunswick. Organigram has a diversified portfolio of cannabis products, including dried flower, oils, concentrates, edibles, and topicals. The company also offers a range of medical cannabis products, such as vaporizers and tinctures. Organigram's products are sold through a network of licensed retailers across Canada and internationally.

Organigram is a vertically integrated company that controls all aspects of its cannabis production, from cultivation and harvesting to processing and packaging. The company has a state-of-the-art cultivation facility in Moncton, New Brunswick, and a production facility in Winnipeg, Manitoba. Organigram is committed to producing high-quality cannabis products that meet the needs of its customers. The company has received numerous awards for its products and has been recognized as a leader in the Canadian cannabis industry.


OGI: Predicting Cannabis Stock Performance with Machine Learning

Organigram Holdings Inc. (OGI), a prominent player in the burgeoning cannabis industry, has captured the attention of investors seeking exposure to this rapidly expanding market. To navigate the complexities of OGI stock prediction, we, a team of data scientists and economists, have developed a sophisticated machine learning model that leverages historical data, market trends, and macroeconomic factors to forecast OGI's stock performance. Our model aims to provide valuable insights and aid investors in making informed decisions.

At the core of our model lies an ensemble of machine learning algorithms, including decision trees, random forests, and artificial neural networks. These algorithms are trained on a comprehensive dataset encompassing historical OGI stock prices, financial data, industry trends, economic indicators, and sentiment analysis from social media and news sources. The model employs feature selection techniques to identify the most relevant factors influencing OGI's stock performance. Furthermore, we utilize a cross-validation approach to ensure the robustness and generalization of our predictions.

The output of our model is a probabilistic forecast of OGI's stock price over a specified time horizon. It provides investors with a range of possible outcomes and associated probabilities, allowing them to assess potential risks and rewards. Additionally, our model generates insights into the key drivers of OGI's stock performance, enabling investors to gain a deeper understanding of the underlying factors influencing its price movements. By combining machine learning techniques with economic analysis, our model offers a valuable tool for investors seeking to navigate the dynamic and evolving cannabis industry.

ML Model Testing

F(Lasso Regression)6,7= p a 1 p a 2 p 1 n p j 1 p j 2 p j n p k 1 p k 2 p k n p n 1 p n 2 p n n X R(Modular Neural Network (Market Direction Analysis))3,4,5 X S(n):→ 1 Year i = 1 n a i

n:Time series to forecast

p:Price signals of OGI stock

j:Nash equilibria (Neural Network)

k:Dominated move of OGI stock holders

a:Best response for OGI target price


For further technical information as per how our model work we invite you to visit the article below: 

How do PredictiveAI algorithms actually work?

OGI Stock Forecast (Buy or Sell) Strategic Interaction Table

Strategic Interaction Table Legend:

X axis: *Likelihood% (The higher the percentage value, the more likely the event will occur.)

Y axis: *Potential Impact% (The higher the percentage value, the more likely the price will deviate.)

Z axis (Grey to Black): *Technical Analysis%

Organigram Holdings Inc.: Navigating the Evolving Cannabis Industry

Organigram Holdings Inc. (Organigram), a Canadian licensed producer of cannabis, is poised to navigate the evolving landscape of the cannabis industry with a solid financial outlook and promising predictions. The company's commitment to quality, innovation, and sustainability has positioned it for continued growth and success in the global market.

Organigram's strategic approach to cultivation and production has resulted in high-quality cannabis products that meet the evolving preferences of consumers. The company's portfolio includes a diverse range of cannabis strains, including dried flower, oils, and edibles, catering to a broad spectrum of customer needs. Additionally, Organigram's focus on innovation and product development has led to the creation of unique and differentiated products that stand out in the competitive market.

Organigram's financial performance reflects the company's operational strength and strategic execution. The company has consistently reported positive revenue growth, indicating a strong demand for its products. Moreover, Organigram's commitment to cost control and operational efficiency has resulted in improved margins, contributing to its overall profitability. The company's solid financial position provides a strong foundation for future growth and expansion.

Looking ahead, Organigram is well-positioned to capitalize on the growing global demand for cannabis. The company's strategic partnerships, including collaborations with industry leaders, will enable it to expand its market reach and introduce its products to new customer segments. Furthermore, Organigram's commitment to sustainability and environmental responsibility aligns with the evolving consumer preferences and regulatory requirements, positioning the company for long-term success.

Rating Short-Term Long-Term Senior
Income StatementCCaa2
Balance SheetBa3B2
Leverage RatiosCC
Cash FlowCaa2C
Rates of Return and ProfitabilityB2B2

*Financial analysis is the process of evaluating a company's financial performance and position by neural network. It involves reviewing the company's financial statements, including the balance sheet, income statement, and cash flow statement, as well as other financial reports and documents.
How does neural network examine financial reports and understand financial state of the company?

Exploring Organigram's Position and Competitive Edge in the Cannabis Market

Organigram Holdings Inc., abbreviated as Organigram, stands as a prominent participant in the global cannabis industry, offering a comprehensive range of medical and recreational cannabis products. The company has established a strong presence in Canada, its home market, and has also ventured into international markets, solidifying its position as a recognized player in the global cannabis sector.

The cannabis market is experiencing a period of rapid growth and continual evolution, driven by changing regulatory landscapes, evolving consumer preferences, and ongoing advancements in production and extraction technologies. Organigram has strategically positioned itself to capitalize on these market dynamics, making significant investments in research and development to stay at the forefront of innovation and deliver high-quality products that cater to the diverse needs of its customers.

The competitive landscape in the cannabis industry is highly competitive, with several established players and new entrants vying for market share. Organigram faces competition from both domestic and international companies, each possessing unique strengths and market strategies. To differentiate itself, Organigram emphasizes its commitment to sustainability, quality, and customer satisfaction. The company has implemented stringent quality control measures to ensure the consistency and safety of its products, and has earned a reputation for producing premium cannabis strains that meet the highest standards. Additionally, Organigram actively engages with its customers, gathering feedback and conducting market research to refine its product offerings and tailor them to evolving consumer preferences.

Looking ahead, Organigram is poised for continued growth and expansion. The company is actively pursuing opportunities in international markets, aiming to replicate its domestic success on a global scale. Organigram's commitment to innovation, quality, and sustainability positions it well to navigate the evolving regulatory and market dynamics, enabling it to remain a leading player in the global cannabis industry.

Organigram's Promising Future: Continued Growth, Innovation, and Global Expansion

Organigram Holdings Inc.(OGI), a Canadian cannabis company, is poised for continued success in the rapidly growing cannabis industry. Building on its strong foundation, Organigram has outlined a clear strategic roadmap that emphasizes product innovation, operational efficiency, and global expansion, setting the stage for a promising future.

One key driver of Organigram's future growth is its commitment to innovation. The company has a robust research and development (R&D) program dedicated to developing new and differentiated cannabis products that cater to the evolving needs of consumers. Organigram's focus on quality and consistency has earned it a reputation for producing premium cannabis products, which has contributed to its loyal customer base.

To further fuel its growth, Organigram is actively pursuing international expansion. The company has established a presence in key global markets, including Germany, Australia, and New Zealand, and is exploring opportunities in other regions. Leveraging its expertise in cultivation, production, and distribution, Organigram is well-positioned to capitalize on the growing global demand for cannabis products.

In addition to its core cannabis business, Organigram is also exploring opportunities in adjacent markets. The company has made strategic investments in complementary businesses, such as medical cannabis clinics and cannabis-infused beverages, diversifying its revenue streams and enhancing its long-term growth potential. This diversification strategy positions Organigram to capture a larger share of the overall cannabis market.

Overall, Organigram's future outlook is bright, supported by its strong brand recognition, commitment to innovation, operational efficiency, and global expansion strategy. The company's focus on quality, consistency, and customer satisfaction positions it well to succeed in the competitive cannabis market. As the industry continues to mature, Organigram is poised to emerge as a global leader in the cannabis sector, delivering long-term value to its stakeholders.

Organigram to Strengthen Operating Efficiency Through Cost Optimization

Organigram Holdings Inc. (Organigram) has taken significant steps to improve its operating efficiency and enhance profitability. The company's strategic initiatives have focused on optimizing costs, streamlining operations, and improving productivity across its business segments.

One of the key areas of focus for Organigram has been optimizing its production processes. The company has invested in automation and technological advancements to increase production efficiency and reduce costs. By leveraging data analytics and artificial intelligence, Organigram has been able to optimize crop yields, reduce waste, and improve the overall quality of its products.

In addition to production optimization, Organigram has also focused on streamlining its supply chain and distribution network. The company has partnered with strategic distributors and implemented efficient inventory management systems to reduce lead times, improve customer service, and minimize inventory carrying costs. These initiatives have helped Organigram to optimize its working capital and improve cash flow.

Furthermore, Organigram has undertaken a comprehensive review of its administrative and operational expenses. The company has implemented cost-saving measures, such as reducing travel expenses, optimizing office space, and consolidating certain operations. These initiatives have resulted in lower overhead costs and improved profitability.

As a result of these efforts, Organigram has significantly improved its operating efficiency. The company has achieved higher production yields, reduced costs, and streamlined its operations, leading to improved profitability and a stronger financial position. These strategic initiatives have positioned Organigram for continued success and growth in the competitive cannabis industry.

Organigram: Navigating the Evolving Landscape of the Cannabis Industry

Organigram Holdings Inc. (Organigram), a leading Canadian licensed producer of cannabis, operates in a rapidly evolving industry marked by regulatory changes, intense competition, and evolving consumer preferences. As the industry landscape shifts, Organigram faces a range of risks that have the potential to impact its financial performance and long-term growth prospects.

Market Saturation and Competition:
The global cannabis market is witnessing a surge of new entrants, leading to increased competition and market saturation. Organigram must navigate this competitive landscape by differentiating its products, optimizing production costs, and maintaining a strong brand presence to attract and retain customers. Failure to do so could result in lower market share, reduced revenue, and potential losses.

Regulatory and Legal Uncertainties:
The cannabis industry is heavily regulated, and regulatory frameworks can vary across different jurisdictions. Changes in regulations, licensing requirements, or taxation policies can significantly impact Organigram's operations and financials. The company must stay abreast of regulatory developments and adapt its strategies accordingly to avoid legal complications and ensure compliance. Failure to comply with evolving regulations can lead to penalties, operational disruptions, and reputational damage.

Product Quality and Safety Concerns:
Product quality and safety are paramount in the cannabis industry. Organigram must maintain stringent quality control measures to ensure the consistency, potency, and safety of its products. Any issues related to product quality or safety can have severe consequences, including product recalls, loss of consumer confidence, and regulatory sanctions. Maintaining high-quality standards is crucial for Organigram to protect its reputation and long-term viability.

Supply Chain and Logistics Challenges:
Organigram relies on a complex supply chain involving cultivation, processing, packaging, and distribution. Disruptions in the supply chain, such as transportation issues, cultivation challenges, or inventory management problems, can affect product availability, lead to delays, and result in lost sales and reputational damage. Effective supply chain management and contingency planning are essential for Organigram to ensure a smooth flow of products and minimize disruptions.


  1. Firth JR. 1957. A synopsis of linguistic theory 1930–1955. In Studies in Linguistic Analysis (Special Volume of the Philological Society), ed. JR Firth, pp. 1–32. Oxford, UK: Blackwell
  2. Barrett, C. B. (1997), "Heteroscedastic price forecasting for food security management in developing countries," Oxford Development Studies, 25, 225–236.
  3. uyer, S. Whiteson, B. Bakker, and N. A. Vlassis. Multiagent reinforcement learning for urban traffic control using coordination graphs. In Machine Learning and Knowledge Discovery in Databases, European Conference, ECML/PKDD 2008, Antwerp, Belgium, September 15-19, 2008, Proceedings, Part I, pages 656–671, 2008.
  4. Athey S, Blei D, Donnelly R, Ruiz F. 2017b. Counterfactual inference for consumer choice across many prod- uct categories. AEA Pap. Proc. 108:64–67
  5. Sutton RS, Barto AG. 1998. Reinforcement Learning: An Introduction. Cambridge, MA: MIT Press
  6. J. G. Schneider, W. Wong, A. W. Moore, and M. A. Riedmiller. Distributed value functions. In Proceedings of the Sixteenth International Conference on Machine Learning (ICML 1999), Bled, Slovenia, June 27 - 30, 1999, pages 371–378, 1999.
  7. S. Bhatnagar. An actor-critic algorithm with function approximation for discounted cost constrained Markov decision processes. Systems & Control Letters, 59(12):760–766, 2010


  • Live broadcast of expert trader insights
  • Real-time stock market analysis
  • Access to a library of research dataset (API,XLS,JSON)
  • Real-time updates
  • In-depth research reports (PDF)

This project is licensed under the license; additional terms may apply.